Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
885
datasets available to search
ShareScore release 0.9.0
Dataset results
885 results for “cyclophosphamide”
Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant Chemotherapy
ClinicalTrials.gov study NCT04137640. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate Change in Disease Activity of Subcutaneous (SC) Epcoritamab Combined With Intravenous and Oral Rituximab, Cyclophosphamide, Doxorubicin Hydrochloride, Vincristine, and Prednisone (
ClinicalTrials.gov study NCT05578976. IPD Sharing: YES. Countries: 31. Publications: 0.
Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma
ClinicalTrials.gov study NCT01947062. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination Chemotherapy With or Without Cyclophosphamide and Prednisone in Treating Older Patients With Multiple Myeloma
ClinicalTrials.gov study NCT00002653. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Pembrolizumab Added to the Standard First-Line Therapy of Cyclophosphamide, Bortezomib, and Dexamethasone (CyBorD) for NDMM NTE
ClinicalTrials.gov study NCT04258683. IPD Sharing: NO. Countries: 1. Publications: 0.
Cyclophosphamide and Docetaxel or Doxorubicin in Treating Women With Newly Diagnosed Breast Cancer That Can Be Removed by Surgery
ClinicalTrials.gov study NCT00801411. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cyclophosphamide and Veliparib in Treating Patients With Locally Advanced or Metastatic Breast Cancer
ClinicalTrials.gov study NCT01351909. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of High-Dose Cyclophosphamide in Patients With Severe Autoimmune Hematologic Disease
ClinicalTrials.gov study NCT00010387. IPD Sharing: Not stated. Countries: 1. Publications: 0.
RIC alloBMT With Post-transplant Cyclophosphamide for Refractory Systemic Sclerosis
ClinicalTrials.gov study NCT05298358. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Treatment of Larotaxel/Docetaxel, +/- Trastuzumab, After Anthracycline-cyclophosphamide in Breast Cancer Patients
ClinicalTrials.gov study NCT00485979. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Decitabine, Doxorubicin, and Cyclophosphamide in Treating Children With Relapsed or Refractory Solid Tumors or Neuroblastoma
ClinicalTrials.gov study NCT00075634. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of Neoadjuvant Docetaxel and Cyclophosphamide in Locally Advanced or Node Positive Primary Breast Cancer With Companion Pharmacokinetic and Pharmacogenomic Analyses
ClinicalTrials.gov study NCT01540110. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Comparison of Reduced Dose Total Body Irradiation (TBI) and Cyclophosphamide With Fludarabine and Melphalan Reduced Intensity Conditioning in Adults With Acute Lymphoblastic Leukaemia (ALL) in Compl
ClinicalTrials.gov study NCT03821610. IPD Sharing: NO. Countries: 1. Publications: 0.
Vedolizumab Plus Post-transplant Cyclophosphamide and Short Course Tacrolimus for the Prevention of Graft Versus Host Disease in Patients Undergoing Allogeneic Hematopoietic Cell Transplantation After
ClinicalTrials.gov study NCT06815003. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Fludarabine and Cyclophosphamide With or Without Rituximab Before CD19 Chimeric Antigen Receptor T Cells for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma
ClinicalTrials.gov study NCT05052528. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Liposomal Mitoxantrone Hydrochloride Injection,Cyclophosphamide, Vincristine and Prednisone in the Treatment of PTCL
ClinicalTrials.gov study NCT04548700. IPD Sharing: Not stated. Countries: 1. Publications: 0.
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
ClinicalTrials.gov study NCT05745714. IPD Sharing: YES. Countries: 14. Publications: 0.
Epirubicin Versus Docetaxel Plus Cyclophosphamide in Lymph Node Negative, ER-positive, Her2-negative Breast Cancer
ClinicalTrials.gov study NCT02549677. IPD Sharing: NO. Countries: 1. Publications: 0.
Cyclophosphamide and Etoposide as a Metronomic Therapy in Advanced Head and Neck Squamous Cell Cancer
ClinicalTrials.gov study NCT07361133. IPD Sharing: NO. Countries: 1. Publications: 0.
IRX-2, Cyclophosphamide, and Nivolumab in Treating Patients With Recurrent or Metastatic and Refractory Liver Cancer
ClinicalTrials.gov study NCT03655002. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.